UniProtKB/Swiss-Prot Q02763: Variant p.Lys294Asn

Angiopoietin-1 receptor
Gene: TEK
Feedback?

Variant information Variant position:

294 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Asparagine (N) at position 294 (K294N, p.Lys294Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (K) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In GLC3E; uncertain significance; 10-fold decrease of Tyr-1102 phosphorylation; no effect on membrane location. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs146169480 [ dbSNP | Ensembl ]

Sequence information Variant position:

294 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1124 The length of the canonical sequence.
Location on the sequence:

CKSYVFCLPDPYGCSCATGW K GLQCNEACHPGFYGPDCKLR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         CKSYVFCLPDPYGCSCATGWKGLQCNEACHPGFYGPDCKLR

Mouse                         CKSYVFCLPDPYGCSCATGWRGLQCNEACPSGYYGPDCKLR

Bovine                        CKSFVFCLPDPYGCSCATGWKGLQCNEACQPGYYGPDCKLR

Zebrafish                     CRALVFCLRDPYGCSCASGWRGLSCNDACPDGYYGAGCTQK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	23 – 1124	Angiopoietin-1 receptor
Topological domain	23 – 748	Extracellular
Domain	254 – 299	EGF-like 2
Disulfide bond	289 – 298

Literature citations
Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.
Souma T.; Tompson S.W.; Thomson B.R.; Siggs O.M.; Kizhatil K.; Yamaguchi S.; Feng L.; Limviphuvadh V.; Whisenhunt K.N.; Maurer-Stroh S.; Yanovitch T.L.; Kalaydjieva L.; Azmanov D.N.; Finzi S.; Mauri L.; Javadiyan S.; Souzeau E.; Zhou T.; Hewitt A.W.; Kloss B.; Burdon K.P.; Mackey D.A.; Allen K.F.; Ruddle J.B.; Lim S.H.; Rozen S.; Tran-Viet K.N.; Liu X.; John S.; Wiggs J.L.; Pasutto F.; Craig J.E.; Jin J.; Quaggin S.E.; Young T.L.;
J. Clin. Invest. 126:2575-2587(2016)
Cited for: INVOLVEMENT IN GLC3E; VARIANTS GLC3E 19-THR--ARG-210 DEL; TYR-233; ASN-294 AND CYS-611; CHARACTERIZATION OF VARIANTS GLC3E 19-THR--ARG-210 DEL; TYR-233; ASN-294 AND CYS-611; SUBCELLULAR LOCATION; MUTAGENESIS OF CYS-224;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.